Immuron Limited (IMRN): Price and Financial Metrics
IMRN Price/Volume Stats
| Current price | $1.84 | 52-week high | $2.87 |
| Prev. close | $1.74 | 52-week low | $1.50 |
| Day low | $1.77 | Volume | 31,659 |
| Day high | $1.89 | Avg. volume | 22,396 |
| 50-day MA | $1.79 | Dividend yield | N/A |
| 200-day MA | $1.94 | Market Cap | 10.76M |
IMRN Stock Price Chart Interactive Chart >
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
IMRN Price Returns
| 1-mo | 6.36% |
| 3-mo | 6.36% |
| 6-mo | -11.54% |
| 1-year | -19.30% |
| 3-year | -24.44% |
| 5-year | N/A |
| YTD | 8.24% |
| 2024 | -9.33% |
| 2023 | -9.86% |
| 2022 | -16.80% |
| 2021 | N/A |
| 2020 | N/A |
Continue Researching IMRN
Want to see what other sources are saying about Immuron Ltd's financials and stock price? Try the links below:Immuron Ltd (IMRN) Stock Price | Nasdaq
Immuron Ltd (IMRN) Stock Quote, History and News - Yahoo Finance
Immuron Ltd (IMRN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...